Diabetic retinopathy can be treated with steroidsTriamcinolone, a corticosteroid (steroid) when administered in injectable form, could be highly useful to slow down the progression of proliferative diabetic retinopathy, which is a complication of diabetes leading to vision loss or blindness.

Treatment based on steroids cannot be routinely recommended at this point of time because of safety issues despite of the fact that steroids work, according to Neil M. Bressler, the James P. Gills Professor of Ophthalmology and chief of the Retina Division of the Johns Hopkins Wilmer Eye Institute, chair of the government-sponsored Diabetic Retinopathy Clinical Research Network.

The finding was revealed in a study by researchers led by specialists at the Johns Hopkins Wilmer Eye Institute and this study was published in an issue of the Archives of Ophthalmology.